Cargando…
A novel hybrid bioprocess strategy addressing key challenges of advanced biomanufacturing
Monoclonal antibodies (mAb) are commonly manufactured by either discontinuous operations like fed-batch (FB) or continuous processes such as steady-state perfusion. Both process types comprise opposing advantages and disadvantages in areas such as plant utilization, feasible cell densities, media co...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349264/ https://www.ncbi.nlm.nih.gov/pubmed/37456731 http://dx.doi.org/10.3389/fbioe.2023.1211410 |